The downregulation of EPHB2, involved in cell cycle processes, and LEFTY1, involved in intestinal mucosal immunity and TGF-β signaling, is a common feature also observed in colorectal cancers and Crohn’s disease, respectively [64, 65]. This evidence concerns the gene LEFTY1 and Crohn disease.